Intracellular oligomeric amyloid-beta rapidly regulates GluA1 subunit of AMPA receptor in the hippocampus

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Whitcomb, Daniel J ^a,b   Hogg, Ellen L ^a,b   Regan, Philip ^a,b   Piers, Thomas ^a,b   Narayan, Priyanka ^c   Whitehead, Garry ^a,b   Winters, Bryony L ^a,b   Kim, Dong Hyun ^a   Kim, Eunjoon ^d   St George Hyslop, Peter ^e   Klenerman, David ^c   Collingridge, Graham L ^a,b   Jo, Jihoon ^a   Cho, Kwangwook ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; AMYLOID BETA PROTEIN; CALCIUM; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 1; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 2;

ALZHEIMER DISEASE; ANIMAL; CYTOPLASM; HIPPOCAMPUS; MALE; METABOLISM; NERVE CELL; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TRANSPORT; RAT; SYNAPSE; WISTAR RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CALCIUM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOPLASM; HIPPOCAMPUS; MALE; NEURONS; PHOSPHORYLATION; PROTEIN TRANSPORT; RATS; RATS, WISTAR; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; SYNAPSES;

EID: 84930966068     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10934     Document Type: Article

References (72)

1. Spires-Jones, T. L. & Hyman, B.T. The intersection of amyloid beta and tau at synapses in Alzheimer's disease. Neuron 82, 756-771 (2014).
2. Crimins, J. L, Pooler, A., Polydoro, M., Luebke, J. I. & Spires-Jones, T. L. The intersection of amyloid beta and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease. Ageing Res Rev 12, 757-763 (2013).
3. Cullen, W. K., Suh, Y. H., Anwyl, R. & Rowan, M. J. Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments. Neuroreport 8, 3213-3217 (1997).
4. Wang, Q., Walsh, D.M., Rowan, M.J., Selkoe, D. J. & Anwyl, R. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J Neurosci 24, 3370-3378 (2004).
5. Jo. J. et al. Abeta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3beta. Nat Neurosci 14, 545-547 (2011).
6. Walsh, D. M. et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539 (2002).
7. Dinamarca, M. C., Rios, J. A. & Inestrosa N. C. Postsynaptic Receptors for Amyloid-beta Oligomers as Mediators of Neuronal Damage in Alzheimer's Disease. Front Physiol 3, 464 (2012).
8. Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W. & Strittmatter, S. M. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 1128-1132 (2009).
9. Chen, S., Yadav, S. P. & Surewicz, W. K. Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues. J Biol Chem 285, 26377-26383 (2010).
10. Larson, M. et al. The complex PrP(c)-Fyn couples human oligomeric Abeta with pathological tau changes in Alzheimer's disease. J Neurosci 32, 16857-16871a (2012).
11. Kudo, W. et al. Cellular prion protein is essential for oligomeric amyloid-beta-induced neuronal cell death. Hum Mol Genet 21, 1138-1144 (2012).
12. Um, J. W. et al. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein. Neuron 79, 887-902 (2013).
13. Nicoll, A. J. et al. Amyloid-beta nanotubes are associated with prion protein-dependent synaptotoxicity. Nat Commun 4, 2416 (2013).
14. Lin, H., Bhatia, R. & Lal, R. Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J 15, 2433-2444 (2001).
15. Demuro, A., Mina, E., Kayed, R., Milton, S. C., Parker, I & Glabe, C. G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280, 17294-17300 (2005).
16. Jang, H. et al. Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome. Proc Natl Acad Sci U S A 107, 6538-6543 (2010).
17. Lin, H. & Arispe, N. J. Single-cell screening of cytosolic [Ca] reveals cell-selective action by the Alzheimer's Abeta peptide ion channel. Cell Stress Chaperones, 20, 333-342 (2015).
18. Kessels, H. W, Nguyen, L. N., Nabavi, S. & Malinow, R. The prion protein as a receptor for amyloid-beta. Nature 466, E3-4; discussion E4-5 (2010).
19. Balducci, C. et al. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc Natl Acad Sci U S A 107, 2295-2300 (2010).
20. Cisse, M., Sanchez, P.E., Kim, D.H., Ho., K., Yu., GQ. & Mucke, L. Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J Neurosci 31, 10427-10431 (2011).
21. LaFerla, F. M., Green, K. N. & Oddo, S. Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8, 499-509 (2007).
22. Mohamed, A. & Posse de Chaves, E. Abeta internalization by neurons and glia. Int J Alzheimers Dis 2011, 127984 (2011).
23. Yazawa, H et al. Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. FASEB J 15, 2454-2462 (2001).
24. Nagele, R. G., D'Andrea, M. R., Anderson, W. J. & Wang, H. Y. Intracellular accumulation of beta-amyloid (1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110, 199-211 (2002).
25. Clifford, P. M. et al. Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons. Brain Res 1142, 223-236 (2007).
26. Yankner, B. A., Duffy, L. K. & Kirschner, D. A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250, 279-282 (1990).
27. Takadera, T., Sakura, N., Mohri, T. & Hashimoto, T. Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention. Neurosci Lett 161, 41-44 (1993).
28. Narayan, P. et al. The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-beta(1-40) peptide. Nat Struct Mol Biol 19, 79-83 (2012).
29. McGlade-McCulloh, E., Yamamoto, H., Tan, S. E., Brickey, D. A. & Soderling, T. R. Phosphorylation and regulation of glutamate receptors by calcium/calmodulin-dependent protein kinase II. Nature 362, 640-642 (1993).
30. Lledo, P. M., Hjelmstad, G. O., Mukherji, S., Soderling, T. R., Malenka, R. C. & Nicoll, R. A. Calcium/calmodulin-dependent kinase II and long-term potentiation enhance synaptic transmission by the same mechanism. Proc Natl Acad Sci U S A 92, 11175-11179 (1995).
31. Mulkey, R. M., Endo, S., Shenolikar, S. & Malenka, R. C. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature 369, 486-488 (1994).
32. Frey, U., Huang, Y. Y. & Kandel, E. R. Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 260, 1661-1664 (1993).
33. Nayak, A., Zastrow, D. J., Lickteig, R., Zahniser, N. R., Browning, M. D. Maintenance of late-phase LTP is accompanied by PKA-dependent increase in AMPA receptor synthesis. Nature 394, 680-683 (1998).
34. Hayashi, Y., Shi, S. H., Esteban, J. A., Piccini, A., Poncer, J. C. & Malinow, R. Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science 287, 2262-2267 (2000).
35. Wang, J. H. & Kelly, P. T. Postsynaptic injection of CA2+/CaM induces synaptic potentiation requiring CaMKII and PKC activity. Neuron 15, 443-452 (1995).
36. Clem, R. L., Anggono, V. & Huganir, R. L. PICK1 regulates incorporation of calcium-permeable AMPA receptors during cortical synaptic strengthening. J Neurosci 30, 6360-6366 (2010).
37. Swanson, G.T. & Kamboj, S. K., Cull-Candy, SG. Single-channel properties of recombinant AMPA receptors depend on RNA editing, splice variation, and subunit composition. J Neurosci 17, 58-69 (1997).
38. Man, H. Y., Sekine-Aizawa, Y. & Huganir, R. L. Regulation of {alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking through PKA phosphorylation of the Glu receptor 1 subunit. Proc Natl Acad Sci U S A 104, 3579-3584 (2007).
39. Roche, K. W., O'Brien, R. J., Mammen, A. L., Bernhardt, J. & Huganir, R. L. Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 16, 1179-1188 (1996).
40. He, K., Song, L., Cummings, L. W., Goldman, J., Huganir, R. L. & Lee, H. K. Stabilization of Ca2+-permeable AMPA receptors at perisynaptic sites by GluR1-S845 phosphorylation. Proc Natl Acad Sci U S A 106, 20033-20038 (2009).
41. Samoilova, M. V., Buldakova, S. L., Vorobjev, V. S., Sharonova, I. N. & Magazanik, L. G. The open channel blocking drug, IEM-1460, reveals functionally distinct alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors in rat brain neurons. Neuroscience 94, 261-268 (1999).
42. Almeida, C. G. et al. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis 20, 187-198 (2005).
43. Hsieh, H. et al. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52, 831-843 (2006).
44. Gu, Z, Liu, W & Yan, Z. {beta}-Amyloid impairs AMPA receptor trafficking and function by reducing Ca2+/calmodulin-dependent protein kinase II synaptic distribution. J Biol Chem 284, 10639-10649 (2009).
45. Monfort, P. & Felipo, V. Amyloid-beta impairs, and ibuprofen restores, the cGMP pathway, synaptic expression of AMPA receptors and long-term potentiation in the hippocampus. J Alzheimers Dis 22, 795-809 (2010).
46. Hartley, DM et al. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19, 8876-8884 (1999).
47. Tozaki, H. et al. The inhibitory and facilitatory actions of amyloid-beta peptides on nicotinic ACh receptors and AMPA receptors. Biochem Biophys Res Commun 294, 42-45 (2002).
48. Ye, C., Walsh, D. M., Selkoe, D. J & Hartley, D. M. Amyloid beta-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-D-aspartate (NMDA) versus non-NMDA receptor/channel activation. Neurosci Lett 366, 320-325 (2004).
49. Wang, D., Govindaiah, G., Liu, R., De Arcangelis, V, Cox, C. L. & Xiang, Y. K. Binding of amyloid beta peptide to beta2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity. FASEB J 24, 3511-3521 (2010).
50. Carriedo, S. G., Yin, H. Z., Sensi, S. L. & Weiss, J. H. Rapid Ca2+ entry through Ca2+-permeable AMPA/Kainate channels triggers marked intracellular Ca2+ rises and consequent oxygen radical production. J Neurosci 18, 7727-7738 (1998).
51. Sensi, S. L., Yin, H. Z., Carriedo, S. G., Rao, S. S. & Weiss, J. H. Preferential Zn2+ influx through Ca2+-permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production. Proc Natl Acad Sci U S A 96, 2414-2419 (1999).
52. Oh, M. C., Derkach, V. A. & Guire, E. S., Soderling, T. R. Extrasynaptic membrane trafficking regulated by GluR1 serine 845 phosphorylation primes AMPA receptors for long-term potentiation. J Biol Chem 281, 752-758 (2006).
53. Lee, H. K., Takamiya, K., He, K., Song, L. & Huganir, R. L. Specific roles of AMPA receptor subunit GluR1 (GluA1) phosphorylation sites in regulating synaptic plasticity in the CA1 region of hippocampus. J Neurophysiol 103, 479-489 (2010).
54. He, K., Lee, A., Song, L., Kanold, P. O. & Lee, H. K. AMPA receptor subunit GluR1 (GluA1) serine-845 site is involved in synaptic depression but not in spine shrinkage associated with chemical long-term depression. J Neurophysiol 105, 1897-1907 (2011).
55. Opazo, P., Sainlos, M. & Choquet, D. Regulation of AMPA receptor surface diffusion by PSD-95 slots. Curr Opin Neurobiol 22, 453-460 (2012).
56. Pickard, L., Noel, J., Henley, J. M., Collingridge, G. L. & Molnar, E. Developmental changes in synaptic AMPA and NMDA receptor distribution and AMPA receptor subunit composition in living hippocampal neurons. J Neurosci 20, 7922-7931 (2000).
57. Kumar, S. S., Bacci, A., Kharazia, V. & Huguenard, J. R. A developmental switch of AMPA receptor subunits in neocortical pyramidal neurons. J Neurosci 22, 3005-3015 (2002).
58. Brill, J. & Huguenard, J. R. Sequential changes in AMPA receptor targeting in the developing neocortical excitatory circuit. J Neurosci 28, 13918-13928 (2008).
59. Cull-Candy, S., Kelly, L. & Farrant, M. Regulation of Ca2+-permeable AMPA receptors: synaptic plasticity and beyond. Curr Opin Neurobiol 16, 288-297 (2006).
60. Derkach, V. A., Oh, M. C., Guire, E. S. & Soderling, T. R. Regulatory mechanisms of AMPA receptors in synaptic plasticity. Nat Rev Neurosci 8, 101-113 (2007).
61. Feldmeyer, D. et al. Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B. Nat Neurosci 2, 57-64 (1999).
62. Liu, B. et al. Ischemic insults direct glutamate receptor subunit 2-lacking AMPA receptors to synaptic sites. J Neurosci 26, 5309-5319 (2006).
63. Spaethling, J. M, Klein, D. M., Singh, P. & Meaney, D. F. Calcium-permeable AMPA receptors appear in cortical neurons after traumatic mechanical injury and contribute to neuronal fate. J Neurotrauma 25, 1207-1216 (2008).
64. Kwak, S. & Weiss, J. H. Calcium-permeable AMPA channels in neurodegenerative disease and ischemia. Curr Opin Neurobiol 16, 281-287 (2006).
65. Zhang, Y., McLaughlin, R., Goodye,r C., LeBlanc, A. Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons. J Cell Biol 156, 519-529 (2002).
66. Oddo, S., Caccamo, A., Kitazawa, M., Tseng, BP, LaFerla, F. M. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24, 1063-1070 (2003).
67. Gouras, G. K. et al. Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. Proc Natl Acad Sci U S A 97, 1202-1205 (2000).
68. Wegiel, J. et al. Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration. Acta Neuropathol 113, 389-402 (2007).
69. Aoki, M., Volkmann, I., Tjernberg, L. O., Winblad, B. & Bogdanovic, N. Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain. Neuroreport 19, 1085-1089 (2008).
70. D'Andrea, M. R., Nagele, R.G., Wang, H. Y., Peterson, P. A. & Lee, D. H. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38, 120-134 (2001).
71. Ripoli, C. et al. Intracellular accumulation of amyloid-beta (Abeta) protein plays a major role in Abeta-induced alterations of glutamatergic synaptic transmission and plasticity. J Neurosci 34, 12893-12903 (2014).
72. Thomas-Crusells, J., Vieira, A., Saarma, M. & Rivera, C. A. novel method for monitoring surface membrane trafficking on hippocampal acute slice preparation. J Neurosci Methods 125, 159-166 (2003).